Page last updated: 2024-09-04

sk&f 83959 and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

sk&f 83959 has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies

Compound Research Comparison

Studies (sk&f 83959)	Trials (sk&f 83959)	Recent Studies (post-2010) (sk&f 83959)	Studies (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)	Trials (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)	Recent Studies (post-2010) (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
94	0	46	3,859	8	1,052

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andringa, G; Cools, AR; Drukarch, B; Stoof, JC; Vermeulen, RJ	1
Ding, F; Gu, X; Li, A; Wang, D; Yin, Y; Zhang, X; Zhen, X; Zhou, J; Zhou, Z	1

Other Studies

2 other study(ies) available for sk&f 83959 and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Article	Year
Dopamine receptor subtypes as targets for the pharmacotherapy of Parkinson's disease. Advances in pharmacology (San Diego, Calif.), 1998, Volume: 42 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Benzazepines; Dopamine Agonists; Haplorhini; Levodopa; Motor Activity; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1	1998
Activation of phosphatidylinositol-linked D1-like receptor modulates FGF-2 expression in astrocytes via IP3-dependent Ca2+ signaling. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Jun-17, Volume: 29, Issue:24 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Astrocytes; Benzazepines; Calcium Signaling; Cells, Cultured; Culture Media, Conditioned; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Enzyme Inhibitors; Fibroblast Growth Factor 2; Gene Expression Regulation; Inositol 1,4,5-Trisphosphate; Mesencephalon; Mice; Mice, Inbred C57BL; Neurons; Neurotoxins; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tyrosine 3-Monooxygenase	2009

Article

Year

Dopamine receptor subtypes as targets for the pharmacotherapy of Parkinson's disease.

Advances in pharmacology (San Diego, Calif.), 1998, Volume: 42

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Benzazepines; Dopamine Agonists; Haplorhini; Levodopa; Motor Activity; Parkinson Disease, Secondary; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1

1998

Activation of phosphatidylinositol-linked D1-like receptor modulates FGF-2 expression in astrocytes via IP3-dependent Ca2+ signaling.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Jun-17, Volume: 29, Issue:24

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Astrocytes; Benzazepines; Calcium Signaling; Cells, Cultured; Culture Media, Conditioned; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Enzyme Inhibitors; Fibroblast Growth Factor 2; Gene Expression Regulation; Inositol 1,4,5-Trisphosphate; Mesencephalon; Mice; Mice, Inbred C57BL; Neurons; Neurotoxins; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tyrosine 3-Monooxygenase

2009